Erythropoietin therapyforrenat anaemia
Treatmentprotocou
Ervthropoietin isaiven subcutaneousy atadoseof 25-50U/kqthreetimes per week
Thebloodpressure.haemogobin andreticulocytecountshouldbe monitored every 2weeks
Failuretorespond may suggestundertyingcoexistemtiron deficiency.bleeding.malignancy orinfectiom
Benefits
Erythropoietinhasbeendemonstratedtoimproveauality-of-uifescores.exercisetolerance.sexuau
function andcognitivefunction when prescribedforrenatanaemia in dialysis patients
Risks
Disadvantaqesincludethecost andariseinblood pressureinupto30ofpatiemts.particularly during
thefirst6months
There isarisein peripheralvascuar resistanceduetoadecrease in hypoxic vasodilatation and an
increaseinbloodviscositv
ntsandtransient corticat blindness
Encephalopathy
a rarecomplication whicL esuft
